Do elevated eosinophils and basophils indicate type 2 (allergic/atopic) immune activation?

Type 2 immune activation, the physiological driver of allergic and atopic diseases, is characterized by a specific cytokine profile—primarily interleukins IL-4, IL-5, and IL-13—that directly modulates the production and activity of eosinophils and basophils.

Clinical evidence

Peripheral blood markers frequently reflect the underlying inflammatory state in atopic individuals. Research consistently demonstrates a strong correlation between elevated absolute eosinophil counts (AEC) and the severity of conditions such as atopic dermatitis and allergic asthma. In these populations, eosinophil levels often parallel serum IgE concentrations. Furthermore, genetic studies indicate that higher basophil counts independently increase the risk of developing atopic dermatitis, suggesting these cells are not merely markers but active participants in disease progression. In adult females, innate lymphoid cells (ILC2s) may show enhanced Type 2 responsiveness due to higher expression of receptors like ST2, which further stabilizes the production of cytokines that maintain elevated peripheral counts of these granulocytes.

Mechanistic explanations

The presence of these cells on a white blood cell differential is driven by specific molecular pathways:

• Eosinophil Regulation: IL-5 serves as the master regulator of eosinophil biology. It promotes differentiation from bone marrow progenitors, facilitates their release into the bloodstream, and enhances their survival in peripheral tissues.
• Basophil Regulation: While basophils also express IL-5 receptors, they are primarily influenced by the IL-4 and IL-13 axes. These cytokines drive B-cell isotype switching to IgE, which then primes basophils via high-affinity FcεRI receptors.
• Pathogenic Feed-Forward: Once recruited, basophils become a significant source of additional IL-4 and IL-13, while eosinophils release toxic granules (such as major basic protein) and leukotrienes. This creates a self-reinforcing loop of Type 2 inflammation that sustains high levels of both cell types in circulation.

Bottom line

Elevated eosinophils and basophils are well-established biomarkers for Type 2 immune activation. Their presence is mechanistically linked to the IL-5 and IL-4/IL-13 cytokine axes, and clinical evidence strongly supports their use in identifying and monitoring the severity of allergic and atopic conditions.